Press Release

Dropzone AI Secures $37M Series B Funding to Revolutionize Cybersecurity with AI SOC Analysts

Dropzone AI, a pioneer in AI SOC analysts, has successfully raised $37 million in Series B funding, with Theory Ventures leading the investment round. This significant financial boost highlights the industry’s recognition of Dropzone AI’s innovative approach to cybersecurity, leveraging...

Jul 29, 2025 | Press Release

Dropzone AI Secures $37M Series B Funding to Revolutionize Cybersecurity with AI SOC Analysts

Dropzone AI, a pioneer in AI SOC analysts, has successfully raised $37 million in Series B funding, with Theory Ventures leading the investment round. This significant financial boost highlights the industry’s recognition of Dropzone AI’s innovative approach to cybersecurity, leveraging...

Jul 29, 2025 | Press Release

A. Aubrey Bodine’s Legacy: Capturing the Essence of the Early 20th Century Through Photography

A. Aubrey Bodine, celebrated as one of the twentieth century’s finest pictorialists, left an indelible mark on the world of photography with his remarkable documentary pictures. His career, which began in 1923 with the Baltimore Sunday Sun, spanned 47 years,...

Jul 29, 2025 | Press Release

A. Aubrey Bodine’s Legacy: Capturing the Essence of the Early 20th Century Through Photography

A. Aubrey Bodine, celebrated as one of the twentieth century’s finest pictorialists, left an indelible mark on the world of photography with his remarkable documentary pictures. His career, which began in 1923 with the Baltimore Sunday Sun, spanned 47 years,...

Jul 29, 2025 | Press Release

Calidi Biotherapeutics Announces 1-for-12 Reverse Stock Split to Optimize Market Dynamics

Calidi Biotherapeutics Inc. (NYSE American: CLDI), a clinical-stage biotechnology company, has announced a 1-for-12 reverse stock split of its common stock, set to take effect on August 5, 2025. This strategic move, approved by shareholders on July 9 and ratified...

Jul 29, 2025 | Press Release

Calidi Biotherapeutics Announces 1-for-12 Reverse Stock Split to Optimize Market Dynamics

Calidi Biotherapeutics Inc. (NYSE American: CLDI), a clinical-stage biotechnology company, has announced a 1-for-12 reverse stock split of its common stock, set to take effect on August 5, 2025. This strategic move, approved by shareholders on July 9 and ratified...

Jul 29, 2025 | Press Release

Fifty 1 Labs and UAV Corp to Host Virtual Shareholder Teleconference Featuring Nobel Laureate Dr....

Fifty 1 Labs, Inc. (OTC: FITY), in collaboration with UAV Corp (OTC: UMAV), is set to host a virtual shareholder teleconference on July 28, 2025, at 12:00 PM EST, featuring Nobel Laureate Dr. James Orbinski. The event, to be streamed...

Jul 29, 2025 | Press Release

Fifty 1 Labs and UAV Corp to Host Virtual Shareholder Teleconference Featuring Nobel Laureate Dr....

Fifty 1 Labs, Inc. (OTC: FITY), in collaboration with UAV Corp (OTC: UMAV), is set to host a virtual shareholder teleconference on July 28, 2025, at 12:00 PM EST, featuring Nobel Laureate Dr. James Orbinski. The event, to be streamed...

Jul 29, 2025 | Press Release

How to Upgrade from a Basic to a Premium Credit Card in Canada

Want to earn more points, get a higher credit limit, or take advantage of exclusive travel perks? Upgrading your credit card can help unlock a range of additional benefits.   Many credit card companies offer different tiers, or levels. Basic credit...

Jul 28, 2025 | Press Release

15 U.S. Regions Selected for Initiative to Combat Cardiovascular-Kidney-Metabolic Syndrome

The American Heart Association has announced the expansion of its Cardiovascular-Kidney-Metabolic Health Initiative to 15 regions across the United States, targeting the interconnected conditions that significantly increase the risk of heart disease and stroke. This initiative, supported by leading healthcare...

Jul 28, 2025 | Press Release